Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes

Identifieur interne : 004256 ( PascalFrancis/Curation ); précédent : 004255; suivant : 004257

Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes

Auteurs : Sammy Ali [Canada] ; Shaun G. Goodman [Canada] ; Raymond T. Yan [Canada] ; Andrzej Budaj [Pologne] ; Keith A. A. Fox [Royaume-Uni] ; Joel M. Gore [États-Unis] ; David Brieger [Australie] ; Jose Lopez-Sendon [Espagne] ; Anatoly Langer [Canada] ; Frans Van De Werf [Belgique] ; Ph. Gabriel Steg [France] ; Andrew T. Yan [Canada]

Source :

RBID : Pascal:11-0265471

Descripteurs français

English descriptors

Abstract

Background Left ventricular hypertrophy (LVH) is frequently associated with ST depression (STD) on the electrocardiogram (ECG), a so-called strain pattern. Although STD is a well-established adverse prognosticator in non-ST-elevation acute coronary syndrome (NSTE-ACS), the relative prognostic importance of LVH and associated STD has not been elucidated. Methods A total of 7,761 patients with NSTE-ACS in the Global Registry of Acute Coronary Events (GRACE) and ACS-I registries had admission ECGs analyzed at a core laboratory. Left ventricular hypertrophy (determined by Sokolow-Lyon and/ or Casale criteria) was observed in 296 (3.8%) patients. We examined the independent association between LVH (determined by the admission ECG) and outcomes in relation to STD. Results Patients with LVH were older, had more comorbidities and STD, and presented with a higher Killip class. They were less likely to undergo cardiac catheterization (43.1% vs 51.2%, P = .006) and percutaneous coronary intervention (18.3% vs 24.6%, P= .014). Patients with LVH had higher unadjusted mortality at 6 months (10.5% vs 7.1%, P = .038), but similar rates of in-hospital mortality (4.1% vs 3.4%, P = .54) and reinfarction (7.1% vs 7.6%, P = .75). Patients with LVH were more likely to have heart failure in-hospital (21.8% vs 11.8%, P < .001). Among LVH patients, degree of quantitative STD did not predict higher short- or long-term mortality, but was associated with in-hospital heart failure. Multivariable analysis adjusting for other clinical prognosticators of the GRACE risk models revealed that LVH was not a significant independent predictor of in-hospital mortality (adjusted odds ratio = 0.75, 95% CI 0.40-1.41, P = .37) or 6-month mortality (adjusted odds ratio = 0.83, 95% CI 0.52-1.35, P = .44). In contrast, STD remained a strong independent predictor of adverse outcomes. There was no significant interaction between STD and LVH. Conclusions Across the broad spectrum of NSTE-ACS, LVH is associated with adverse prognostic factors including STD. Electrocardiographic-determined LVH provides no significant additional prognostic utility beyond comprehensive risk assessment using the GRACE risk score. The adverse prognosis associated with LVH in NSTE-ACS may be attributable to other prognosticators such as STD.
pA  
A01 01  1    @0 0002-8703
A02 01      @0 AHJOA2
A03   1    @0 Am. heart j.
A05       @2 161
A06       @2 5
A08 01  1  ENG  @1 Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes
A11 01  1    @1 ALI (Sammy)
A11 02  1    @1 GOODMAN (Shaun G.)
A11 03  1    @1 YAN (Raymond T.)
A11 04  1    @1 BUDAJ (Andrzej)
A11 05  1    @1 FOX (Keith A. A.)
A11 06  1    @1 GORE (Joel M.)
A11 07  1    @1 BRIEGER (David)
A11 08  1    @1 LOPEZ-SENDON (Jose)
A11 09  1    @1 LANGER (Anatoly)
A11 10  1    @1 VAN DE WERF (Frans)
A11 11  1    @1 STEG (Ph. gabriel)
A11 12  1    @1 YAN (Andrew T.)
A14 01      @1 Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto @2 Toronto, Ontario @3 CAN @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 9 aut. @Z 12 aut.
A14 02      @1 Postgraduate Medical School, Department of Cardiology, Grochowski Hospital @2 Warsaw @3 POL @Z 4 aut.
A14 03      @1 Cardiovascular Research, Division of Medical and Radiological Sciences, The University of Edinburgh @2 Edinburgh @3 GBR @Z 5 aut.
A14 04      @1 Department of Medicine, University of Massachusetts Medical School @2 Worcester, MA @3 USA @Z 6 aut.
A14 05      @1 Coronary Care Unit, Concord Hospital @2 Sydney @3 AUS @Z 7 aut.
A14 06      @1 Hospital Universitario La Paz @2 Madrid @3 ESP @Z 8 aut.
A14 07      @1 Department of Cardiovascular Medicine, University of Leuven @2 Leuven @3 BEL @Z 10 aut.
A14 08      @1 INSERM U-698 @2 Paris @3 FRA @Z 11 aut.
A14 09      @1 Université Paris 7 @2 Paris @3 FRA @Z 11 aut.
A14 10      @1 Assistance Publique-Hôpitaux de Paris, Centre Hospitalier Bichat-Claude Bernard @2 Paris @3 FRA @Z 11 aut.
A20       @1 878-885
A21       @1 2011
A23 01      @0 ENG
A43 01      @1 INIST @2 2057 @5 354000192140800110
A44       @0 0000 @1 © 2011 INIST-CNRS. All rights reserved.
A45       @0 38 ref.
A47 01  1    @0 11-0265471
A60       @1 P
A61       @0 A
A64 01  1    @0 The American heart journal
A66 01      @0 USA
C01 01    ENG  @0 Background Left ventricular hypertrophy (LVH) is frequently associated with ST depression (STD) on the electrocardiogram (ECG), a so-called strain pattern. Although STD is a well-established adverse prognosticator in non-ST-elevation acute coronary syndrome (NSTE-ACS), the relative prognostic importance of LVH and associated STD has not been elucidated. Methods A total of 7,761 patients with NSTE-ACS in the Global Registry of Acute Coronary Events (GRACE) and ACS-I registries had admission ECGs analyzed at a core laboratory. Left ventricular hypertrophy (determined by Sokolow-Lyon and/ or Casale criteria) was observed in 296 (3.8%) patients. We examined the independent association between LVH (determined by the admission ECG) and outcomes in relation to STD. Results Patients with LVH were older, had more comorbidities and STD, and presented with a higher Killip class. They were less likely to undergo cardiac catheterization (43.1% vs 51.2%, P = .006) and percutaneous coronary intervention (18.3% vs 24.6%, P= .014). Patients with LVH had higher unadjusted mortality at 6 months (10.5% vs 7.1%, P = .038), but similar rates of in-hospital mortality (4.1% vs 3.4%, P = .54) and reinfarction (7.1% vs 7.6%, P = .75). Patients with LVH were more likely to have heart failure in-hospital (21.8% vs 11.8%, P < .001). Among LVH patients, degree of quantitative STD did not predict higher short- or long-term mortality, but was associated with in-hospital heart failure. Multivariable analysis adjusting for other clinical prognosticators of the GRACE risk models revealed that LVH was not a significant independent predictor of in-hospital mortality (adjusted odds ratio = 0.75, 95% CI 0.40-1.41, P = .37) or 6-month mortality (adjusted odds ratio = 0.83, 95% CI 0.52-1.35, P = .44). In contrast, STD remained a strong independent predictor of adverse outcomes. There was no significant interaction between STD and LVH. Conclusions Across the broad spectrum of NSTE-ACS, LVH is associated with adverse prognostic factors including STD. Electrocardiographic-determined LVH provides no significant additional prognostic utility beyond comprehensive risk assessment using the GRACE risk score. The adverse prognosis associated with LVH in NSTE-ACS may be attributable to other prognosticators such as STD.
C02 01  X    @0 002B12A03
C02 02  X    @0 002B12A05
C03 01  X  FRE  @0 Hypertrophie @5 01
C03 01  X  ENG  @0 Hypertrophy @5 01
C03 01  X  SPA  @0 Hipertrofia @5 01
C03 02  X  FRE  @0 Pathologie de l'appareil circulatoire @5 02
C03 02  X  ENG  @0 Cardiovascular disease @5 02
C03 02  X  SPA  @0 Aparato circulatorio patología @5 02
C03 03  X  FRE  @0 Pronostic @5 09
C03 03  X  ENG  @0 Prognosis @5 09
C03 03  X  SPA  @0 Pronóstico @5 09
C03 04  X  FRE  @0 Electrocardiographie @5 10
C03 04  X  ENG  @0 Electrocardiography @5 10
C03 04  X  SPA  @0 Electrocardiografía @5 10
C03 05  X  FRE  @0 Ventricule gauche @5 11
C03 05  X  ENG  @0 Left ventricle @5 11
C03 05  X  SPA  @0 Ventrículo izquierdo @5 11
C03 06  X  FRE  @0 Sousdécalage ST @5 12
C03 06  X  ENG  @0 ST depression @5 12
C03 06  X  SPA  @0 ST depresión(ECG) @5 12
C03 07  X  FRE  @0 Homme @5 13
C03 07  X  ENG  @0 Human @5 13
C03 07  X  SPA  @0 Hombre @5 13
C03 08  X  FRE  @0 Malade @5 14
C03 08  X  ENG  @0 Patient @5 14
C03 08  X  SPA  @0 Enfermo @5 14
C03 09  X  FRE  @0 Susdécalage ST @5 15
C03 09  X  ENG  @0 ST elevation @5 15
C03 09  X  SPA  @0 ST elevación(ECG) @5 15
C03 10  X  FRE  @0 Appareil circulatoire @5 16
C03 10  X  ENG  @0 Circulatory system @5 16
C03 10  X  SPA  @0 Aparato circulatorio @5 16
C03 11  X  FRE  @0 Cardiologie @5 17
C03 11  X  ENG  @0 Cardiology @5 17
C03 11  X  SPA  @0 Cardiología @5 17
C03 12  X  FRE  @0 Syndrome coronaire aigu @4 CD @5 96
C03 12  X  ENG  @0 Acute coronary syndrome @4 CD @5 96
C03 12  X  SPA  @0 Síndrome coronario agudo @4 CD @5 96
C07 01  X  FRE  @0 Electrodiagnostic @5 37
C07 01  X  ENG  @0 Electrodiagnosis @5 37
C07 01  X  SPA  @0 Electrodiagnóstico @5 37
C07 02  X  FRE  @0 Cardiopathie coronaire @5 38
C07 02  X  ENG  @0 Coronary heart disease @5 38
C07 02  X  SPA  @0 Cardiopatía coronaria @5 38
C07 03  X  FRE  @0 Pathologie du myocarde @5 39
C07 03  X  ENG  @0 Myocardial disease @5 39
C07 03  X  SPA  @0 Miocardio patología @5 39
N21       @1 178
N44 01      @1 OTO
N82       @1 OTO

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:11-0265471

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes</title>
<author>
<name sortKey="Ali, Sammy" sort="Ali, Sammy" uniqKey="Ali S" first="Sammy" last="Ali">Sammy Ali</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Goodman, Shaun G" sort="Goodman, Shaun G" uniqKey="Goodman S" first="Shaun G." last="Goodman">Shaun G. Goodman</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Yan, Raymond T" sort="Yan, Raymond T" uniqKey="Yan R" first="Raymond T." last="Yan">Raymond T. Yan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Budaj, Andrzej" sort="Budaj, Andrzej" uniqKey="Budaj A" first="Andrzej" last="Budaj">Andrzej Budaj</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Postgraduate Medical School, Department of Cardiology, Grochowski Hospital</s1>
<s2>Warsaw</s2>
<s3>POL</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Pologne</country>
</affiliation>
</author>
<author>
<name sortKey="Fox, Keith A A" sort="Fox, Keith A A" uniqKey="Fox K" first="Keith A. A." last="Fox">Keith A. A. Fox</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Cardiovascular Research, Division of Medical and Radiological Sciences, The University of Edinburgh</s1>
<s2>Edinburgh</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author>
<name sortKey="Gore, Joel M" sort="Gore, Joel M" uniqKey="Gore J" first="Joel M." last="Gore">Joel M. Gore</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Department of Medicine, University of Massachusetts Medical School</s1>
<s2>Worcester, MA</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Brieger, David" sort="Brieger, David" uniqKey="Brieger D" first="David" last="Brieger">David Brieger</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Coronary Care Unit, Concord Hospital</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Lopez Sendon, Jose" sort="Lopez Sendon, Jose" uniqKey="Lopez Sendon J" first="Jose" last="Lopez-Sendon">Jose Lopez-Sendon</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Hospital Universitario La Paz</s1>
<s2>Madrid</s2>
<s3>ESP</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author>
<name sortKey="Langer, Anatoly" sort="Langer, Anatoly" uniqKey="Langer A" first="Anatoly" last="Langer">Anatoly Langer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Van De Werf, Frans" sort="Van De Werf, Frans" uniqKey="Van De Werf F" first="Frans" last="Van De Werf">Frans Van De Werf</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Department of Cardiovascular Medicine, University of Leuven</s1>
<s2>Leuven</s2>
<s3>BEL</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Belgique</country>
</affiliation>
</author>
<author>
<name sortKey="Steg, Ph Gabriel" sort="Steg, Ph Gabriel" uniqKey="Steg P" first="Ph. Gabriel" last="Steg">Ph. Gabriel Steg</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>INSERM U-698</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>Université Paris 7</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="10">
<s1>Assistance Publique-Hôpitaux de Paris, Centre Hospitalier Bichat-Claude Bernard</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Yan, Andrew T" sort="Yan, Andrew T" uniqKey="Yan A" first="Andrew T." last="Yan">Andrew T. Yan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">11-0265471</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0265471 INIST</idno>
<idno type="RBID">Pascal:11-0265471</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001C87</idno>
<idno type="wicri:Area/PascalFrancis/Curation">004256</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes</title>
<author>
<name sortKey="Ali, Sammy" sort="Ali, Sammy" uniqKey="Ali S" first="Sammy" last="Ali">Sammy Ali</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Goodman, Shaun G" sort="Goodman, Shaun G" uniqKey="Goodman S" first="Shaun G." last="Goodman">Shaun G. Goodman</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Yan, Raymond T" sort="Yan, Raymond T" uniqKey="Yan R" first="Raymond T." last="Yan">Raymond T. Yan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Budaj, Andrzej" sort="Budaj, Andrzej" uniqKey="Budaj A" first="Andrzej" last="Budaj">Andrzej Budaj</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Postgraduate Medical School, Department of Cardiology, Grochowski Hospital</s1>
<s2>Warsaw</s2>
<s3>POL</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Pologne</country>
</affiliation>
</author>
<author>
<name sortKey="Fox, Keith A A" sort="Fox, Keith A A" uniqKey="Fox K" first="Keith A. A." last="Fox">Keith A. A. Fox</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Cardiovascular Research, Division of Medical and Radiological Sciences, The University of Edinburgh</s1>
<s2>Edinburgh</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author>
<name sortKey="Gore, Joel M" sort="Gore, Joel M" uniqKey="Gore J" first="Joel M." last="Gore">Joel M. Gore</name>
<affiliation wicri:level="1">
<inist:fA14 i1="04">
<s1>Department of Medicine, University of Massachusetts Medical School</s1>
<s2>Worcester, MA</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Brieger, David" sort="Brieger, David" uniqKey="Brieger D" first="David" last="Brieger">David Brieger</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Coronary Care Unit, Concord Hospital</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author>
<name sortKey="Lopez Sendon, Jose" sort="Lopez Sendon, Jose" uniqKey="Lopez Sendon J" first="Jose" last="Lopez-Sendon">Jose Lopez-Sendon</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Hospital Universitario La Paz</s1>
<s2>Madrid</s2>
<s3>ESP</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
</affiliation>
</author>
<author>
<name sortKey="Langer, Anatoly" sort="Langer, Anatoly" uniqKey="Langer A" first="Anatoly" last="Langer">Anatoly Langer</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Van De Werf, Frans" sort="Van De Werf, Frans" uniqKey="Van De Werf F" first="Frans" last="Van De Werf">Frans Van De Werf</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Department of Cardiovascular Medicine, University of Leuven</s1>
<s2>Leuven</s2>
<s3>BEL</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Belgique</country>
</affiliation>
</author>
<author>
<name sortKey="Steg, Ph Gabriel" sort="Steg, Ph Gabriel" uniqKey="Steg P" first="Ph. Gabriel" last="Steg">Ph. Gabriel Steg</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>INSERM U-698</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>Université Paris 7</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="10">
<s1>Assistance Publique-Hôpitaux de Paris, Centre Hospitalier Bichat-Claude Bernard</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Yan, Andrew T" sort="Yan, Andrew T" uniqKey="Yan A" first="Andrew T." last="Yan">Andrew T. Yan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">The American heart journal</title>
<title level="j" type="abbreviated">Am. heart j.</title>
<idno type="ISSN">0002-8703</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">The American heart journal</title>
<title level="j" type="abbreviated">Am. heart j.</title>
<idno type="ISSN">0002-8703</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Acute coronary syndrome</term>
<term>Cardiology</term>
<term>Cardiovascular disease</term>
<term>Circulatory system</term>
<term>Electrocardiography</term>
<term>Human</term>
<term>Hypertrophy</term>
<term>Left ventricle</term>
<term>Patient</term>
<term>Prognosis</term>
<term>ST depression</term>
<term>ST elevation</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Hypertrophie</term>
<term>Pathologie de l'appareil circulatoire</term>
<term>Pronostic</term>
<term>Electrocardiographie</term>
<term>Ventricule gauche</term>
<term>Sousdécalage ST</term>
<term>Homme</term>
<term>Malade</term>
<term>Susdécalage ST</term>
<term>Appareil circulatoire</term>
<term>Cardiologie</term>
<term>Syndrome coronaire aigu</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background Left ventricular hypertrophy (LVH) is frequently associated with ST depression (STD) on the electrocardiogram (ECG), a so-called strain pattern. Although STD is a well-established adverse prognosticator in non-ST-elevation acute coronary syndrome (NSTE-ACS), the relative prognostic importance of LVH and associated STD has not been elucidated. Methods A total of 7,761 patients with NSTE-ACS in the Global Registry of Acute Coronary Events (GRACE) and ACS-I registries had admission ECGs analyzed at a core laboratory. Left ventricular hypertrophy (determined by Sokolow-Lyon and/ or Casale criteria) was observed in 296 (3.8%) patients. We examined the independent association between LVH (determined by the admission ECG) and outcomes in relation to STD. Results Patients with LVH were older, had more comorbidities and STD, and presented with a higher Killip class. They were less likely to undergo cardiac catheterization (43.1% vs 51.2%, P = .006) and percutaneous coronary intervention (18.3% vs 24.6%, P= .014). Patients with LVH had higher unadjusted mortality at 6 months (10.5% vs 7.1%, P = .038), but similar rates of in-hospital mortality (4.1% vs 3.4%, P = .54) and reinfarction (7.1% vs 7.6%, P = .75). Patients with LVH were more likely to have heart failure in-hospital (21.8% vs 11.8%, P < .001). Among LVH patients, degree of quantitative STD did not predict higher short- or long-term mortality, but was associated with in-hospital heart failure. Multivariable analysis adjusting for other clinical prognosticators of the GRACE risk models revealed that LVH was not a significant independent predictor of in-hospital mortality (adjusted odds ratio = 0.75, 95% CI 0.40-1.41, P = .37) or 6-month mortality (adjusted odds ratio = 0.83, 95% CI 0.52-1.35, P = .44). In contrast, STD remained a strong independent predictor of adverse outcomes. There was no significant interaction between STD and LVH. Conclusions Across the broad spectrum of NSTE-ACS, LVH is associated with adverse prognostic factors including STD. Electrocardiographic-determined LVH provides no significant additional prognostic utility beyond comprehensive risk assessment using the GRACE risk score. The adverse prognosis associated with LVH in NSTE-ACS may be attributable to other prognosticators such as STD.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0002-8703</s0>
</fA01>
<fA02 i1="01">
<s0>AHJOA2</s0>
</fA02>
<fA03 i2="1">
<s0>Am. heart j.</s0>
</fA03>
<fA05>
<s2>161</s2>
</fA05>
<fA06>
<s2>5</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>ALI (Sammy)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>GOODMAN (Shaun G.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>YAN (Raymond T.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>BUDAJ (Andrzej)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>FOX (Keith A. A.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>GORE (Joel M.)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>BRIEGER (David)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>LOPEZ-SENDON (Jose)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>LANGER (Anatoly)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>VAN DE WERF (Frans)</s1>
</fA11>
<fA11 i1="11" i2="1">
<s1>STEG (Ph. gabriel)</s1>
</fA11>
<fA11 i1="12" i2="1">
<s1>YAN (Andrew T.)</s1>
</fA11>
<fA14 i1="01">
<s1>Canadian Heart Research Centre and Terrence Donnelly Heart Centre, Division of Cardiology, St. Michael's Hospital, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Postgraduate Medical School, Department of Cardiology, Grochowski Hospital</s1>
<s2>Warsaw</s2>
<s3>POL</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Cardiovascular Research, Division of Medical and Radiological Sciences, The University of Edinburgh</s1>
<s2>Edinburgh</s2>
<s3>GBR</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Department of Medicine, University of Massachusetts Medical School</s1>
<s2>Worcester, MA</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="05">
<s1>Coronary Care Unit, Concord Hospital</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="06">
<s1>Hospital Universitario La Paz</s1>
<s2>Madrid</s2>
<s3>ESP</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="07">
<s1>Department of Cardiovascular Medicine, University of Leuven</s1>
<s2>Leuven</s2>
<s3>BEL</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="08">
<s1>INSERM U-698</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="09">
<s1>Université Paris 7</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="10">
<s1>Assistance Publique-Hôpitaux de Paris, Centre Hospitalier Bichat-Claude Bernard</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA20>
<s1>878-885</s1>
</fA20>
<fA21>
<s1>2011</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>2057</s2>
<s5>354000192140800110</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>38 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>11-0265471</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>The American heart journal</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Background Left ventricular hypertrophy (LVH) is frequently associated with ST depression (STD) on the electrocardiogram (ECG), a so-called strain pattern. Although STD is a well-established adverse prognosticator in non-ST-elevation acute coronary syndrome (NSTE-ACS), the relative prognostic importance of LVH and associated STD has not been elucidated. Methods A total of 7,761 patients with NSTE-ACS in the Global Registry of Acute Coronary Events (GRACE) and ACS-I registries had admission ECGs analyzed at a core laboratory. Left ventricular hypertrophy (determined by Sokolow-Lyon and/ or Casale criteria) was observed in 296 (3.8%) patients. We examined the independent association between LVH (determined by the admission ECG) and outcomes in relation to STD. Results Patients with LVH were older, had more comorbidities and STD, and presented with a higher Killip class. They were less likely to undergo cardiac catheterization (43.1% vs 51.2%, P = .006) and percutaneous coronary intervention (18.3% vs 24.6%, P= .014). Patients with LVH had higher unadjusted mortality at 6 months (10.5% vs 7.1%, P = .038), but similar rates of in-hospital mortality (4.1% vs 3.4%, P = .54) and reinfarction (7.1% vs 7.6%, P = .75). Patients with LVH were more likely to have heart failure in-hospital (21.8% vs 11.8%, P < .001). Among LVH patients, degree of quantitative STD did not predict higher short- or long-term mortality, but was associated with in-hospital heart failure. Multivariable analysis adjusting for other clinical prognosticators of the GRACE risk models revealed that LVH was not a significant independent predictor of in-hospital mortality (adjusted odds ratio = 0.75, 95% CI 0.40-1.41, P = .37) or 6-month mortality (adjusted odds ratio = 0.83, 95% CI 0.52-1.35, P = .44). In contrast, STD remained a strong independent predictor of adverse outcomes. There was no significant interaction between STD and LVH. Conclusions Across the broad spectrum of NSTE-ACS, LVH is associated with adverse prognostic factors including STD. Electrocardiographic-determined LVH provides no significant additional prognostic utility beyond comprehensive risk assessment using the GRACE risk score. The adverse prognosis associated with LVH in NSTE-ACS may be attributable to other prognosticators such as STD.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B12A03</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B12A05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Hypertrophie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Hypertrophy</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Hipertrofia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Pathologie de l'appareil circulatoire</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Cardiovascular disease</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Aparato circulatorio patología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Pronostic</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Prognosis</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Pronóstico</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Electrocardiographie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Electrocardiography</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Electrocardiografía</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Ventricule gauche</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Left ventricle</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Ventrículo izquierdo</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Sousdécalage ST</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>ST depression</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>ST depresión(ECG)</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Homme</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Human</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Malade</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Patient</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Enfermo</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Susdécalage ST</s0>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>ST elevation</s0>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>ST elevación(ECG)</s0>
<s5>15</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Appareil circulatoire</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Circulatory system</s0>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Aparato circulatorio</s0>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Cardiologie</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Cardiology</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Cardiología</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Syndrome coronaire aigu</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>Acute coronary syndrome</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Síndrome coronario agudo</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Electrodiagnostic</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Electrodiagnosis</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Electrodiagnóstico</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Cardiopathie coronaire</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Coronary heart disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Cardiopatía coronaria</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Pathologie du myocarde</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Myocardial disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Miocardio patología</s0>
<s5>39</s5>
</fC07>
<fN21>
<s1>178</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004256 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 004256 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:11-0265471
   |texte=   Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024